These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treating chronic heart failure: time to take stock. Niebauer J; Coats AJ Lancet; 1997 Apr; 349(9057):966-7. PubMed ID: 9100617 [No Abstract] [Full Text] [Related]
3. [Clinical efficacy of oral dopaminergic agents: new findings]. Dei Cas L; Metra M; Nodari S; Raccagni D Cardiologia; 1995 Dec; 40(12 Suppl 1):131-8. PubMed ID: 8998705 [No Abstract] [Full Text] [Related]
4. Identification and characterization of dopamine receptors in the cardiovascular system. Goldberg LI; Kohli JD Cardiologia; 1987 Dec; 32(12):1603-7. PubMed ID: 3447717 [No Abstract] [Full Text] [Related]
5. [Dopaminergic stimulation in cardiology: its current status and future strategies]. Cherchi A; Mercuro G Cardiologia; 1987 Dec; 32(12):1631-9. PubMed ID: 3329022 [No Abstract] [Full Text] [Related]
6. Dopamine: pharmacologic and therapeutic aspects. Velasco M; Luchsinger A Am J Ther; 1998 Jan; 5(1):37-43. PubMed ID: 10099036 [TBL] [Abstract][Full Text] [Related]
7. [Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?]. Campa PP; Puddu PE; Schiariti M; Monti F; Dawodu AA; Gentile C; Lilla Della Monica PL; Vaccaro M; De Biase L Cardiologia; 1995 Dec; 40(12 Suppl 1):139-50. PubMed ID: 8998706 [No Abstract] [Full Text] [Related]
8. An elephant among us: the role of dopamine in the pathophysiology of fibromyalgia. Wood PB; Holman AJ J Rheumatol; 2009 Feb; 36(2):221-4. PubMed ID: 19208556 [No Abstract] [Full Text] [Related]
9. [Dopamine receptors. Their role in regulating the activities of the heart and vessels]. Sergeev PV; Valeeva LA; Shimanovskiĭ NL Eksp Klin Farmakol; 1998; 61(1):63-9. PubMed ID: 9575417 [No Abstract] [Full Text] [Related]
10. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists. Kondo T J Neurol; 2002 Sep; 249 Suppl 2():II25-9. PubMed ID: 12375060 [TBL] [Abstract][Full Text] [Related]
11. [Drug therapy in Parkinson's disease]. van Hilten JJ; Roos RA Ned Tijdschr Geneeskd; 1999 Jan; 143(5):234-40. PubMed ID: 10086151 [TBL] [Abstract][Full Text] [Related]
12. Dopamine receptor partial agonists could address the duality of cocaine craving. Childress AR; O'Brien CP Trends Pharmacol Sci; 2000 Jan; 21(1):6-9. PubMed ID: 10637646 [No Abstract] [Full Text] [Related]
14. Improved therapies for Parkinson's disease: life beyond dopamine D2/D3 receptor agonists. Williams M; Wright S; Lloyd GK Trends Pharmacol Sci; 1997 Sep; 18(9):307-10. PubMed ID: 9345846 [No Abstract] [Full Text] [Related]
15. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat. Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422 [TBL] [Abstract][Full Text] [Related]
16. Are there clinically significant differences between dopamine agonists. Stocchi F; Vacca L; Onofrj M Adv Neurol; 2003; 91():259-66. PubMed ID: 12442684 [No Abstract] [Full Text] [Related]